Yestino - The Signal · Pacira BioScienceshttps://yestino.com/zh-CN/entities/pacira-biosciences-769939与 Pacira BioSciences 相关的全部事件zh-CNViatris is buying Pacira BioSciences for $1.65 billion in non-opioid pain pushhttps://yestino.com/zh-CN/events/viatris-is-buying-pacira-biosciences-for-1-65-billion-in-non-b25ecahttps://yestino.com/zh-CN/events/viatris-is-buying-pacira-biosciences-for-1-65-billion-in-non-b25ecaThu, 08 Oct 2026 18:40:24 GMTThe deal, at $36.50 per share, represents a roughly 45% premium and is expected to close by the end of 2026 来源：Quartz